develops tissue-based therapeutic devices including the first tissue heart valve to gain regulatory approval in Europe, subsequently developing “living” vascular grafts and collagen patches.
Saints Capital | 2020 Union St., San Francisco, CA 94123 | (415) 773-2080 | eMail Us
© 2024 All Rights Reserved
© 2022 All Rights Reserved